Vyepti Sales Disappoint But Lundbeck Sees Growth From Expanded Infusion Center Network
Key brands saw growth in the first half of 2021 despite the company’s overall revenues falling, mainly due to generic competition for Northera.
Key brands saw growth in the first half of 2021 despite the company’s overall revenues falling, mainly due to generic competition for Northera.